Ditchcarbon
  • Customers
  1. Organizations
  2. Arix Bioscience
Public Profile
Research Services
GB
updated 2 months ago

Arix Bioscience

Company website

Arix Bioscience, a leading life sciences company headquartered in Great Britain, focuses on advancing innovative therapies in the biotechnology sector. Founded in 2013, Arix has established itself as a key player in the industry, with a strong emphasis on developing and commercialising breakthrough treatments across various therapeutic areas, including oncology and rare diseases. The company is renowned for its unique approach to building and supporting a diverse portfolio of life science companies, leveraging its deep expertise and extensive network. Arix Bioscience's commitment to fostering innovation has positioned it as a prominent venture capital firm, recognised for its strategic investments and successful partnerships. With a robust pipeline of core products and a reputation for excellence, Arix continues to make significant strides in transforming healthcare and improving patient outcomes.

DitchCarbon Score

How does Arix Bioscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

Arix Bioscience's score of 27 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Arix Bioscience's reported carbon emissions

In 2022, Arix Bioscience, headquartered in Great Britain, reported total carbon emissions of approximately 8,890 kg CO2e. This figure includes 3,680 kg CO2e from Scope 1 emissions, 4,410 kg CO2e from Scope 2 emissions (with a market-based total of 8,890 kg CO2e), and 5,210 kg CO2e from Scope 3 emissions. Comparatively, in 2021, the company recorded total emissions of about 7,570 kg CO2e, comprising 4,860 kg CO2e from Scope 1, 2,670 kg CO2e from Scope 2, and 2,940 kg CO2e from Scope 3. This indicates a rise in emissions from 2021 to 2022. Arix Bioscience has not set specific reduction targets or initiatives as part of their climate commitments, nor do they have any climate pledges or SBTi (Science Based Targets initiative) targets. The company’s emissions data is not cascaded from any parent organization, indicating that all reported figures are independently sourced. Overall, Arix Bioscience's emissions reflect their operational impact, and while they have not established formal reduction goals, their commitment to transparency in reporting emissions is evident.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202020212022
Scope 1
5,020
0,000
0,000
Scope 2
5,110
0,000
0,000
Scope 3
90
0,000
0,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Arix Bioscience's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Arix Bioscience is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Arix Bioscience is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

EBIR

ES
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Illumina

US
•
Research and development services (73)
Updated 5 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

EDITA

FI
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250918.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy